Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Pulse Oximeters Market Size & Share Will Reach USD 3,555.9 Million by 2026: Facts & Factors

Published

on

New York, NY, April 19, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “Pulse Oximeters Market By Product Type (Fingertip Oximeter, Handheld Oximeter, Tabletop Oximeter, and Others Oximeter) By End-Use (Hospitals, Healthcare Facilities, Ambulatory Surgical Centers and Homecare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”.

“According to the research report, the global Pulse Oximeters Market was estimated at USD 2,1836.4 Million in 2019 and is expected to reach USD 3,555.9 Million by 2026. The global Pulse Oximeters Market is expected to grow at a compound annual growth rate (CAGR) of 7.24% from 2019 to 2026”.

Pulse Oximeters Market: Key Market Insights Overview

Pulse oximeters have proved to be an efficient method for assessing a patient’s oxygenation status, and they are now commonly used in a number of departments and units in hospitals. Because of the numerous age groups of patients admitted to hospitals and other settings, the demand for pulse oximeters is growing. Patients with cardiac arrest, multisystem injuries, apneic disorders, sickle-cell crises, and drowning events require pulse oximeters. Pulse oximeters are expected to be in high demand in the future due to their large variety of applications.

Request Your Free Sample Report of Pulse Oximeters Market @ https://www.fnfresearch.com/sample/pulse-oximeters-market                               

(The free sample of this report is readily available on request).

Our Free Sample Report Includes:

  • 2020 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 190+ Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of table & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Facts and Factors research methodology

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Key Questions Answered in this Report

1) What were the pre and post-business impacts of COVID-19 on the Pulse Oximeters Market?

2) What is the market size, share of the Pulse Oximeters Market?

3) Who are the top market players in Pulse Oximeters Market?

4) What will be the future market of Pulse Oximeters Market?

Key Offerings:

  • Market Size & Forecast by Revenue | 2020−2026
  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
  • Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
  • Competitive Landscape – Top key vendors and other prominent vendors

Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/pulse-oximeters-market                          

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Pulse Oximeters Market: Industry Major Market Players

  • Spacelabs Healthcare
  • Carefusion Corp.
  • Nihon Kohden Corporation
  • GE Healthcare
  • Philips HealthcareMasimo
  • CAS Medical Systems, Inc.
  • Opto Circuits India Ltd.
  • Nonin Medical, Inc.
  • Medtronic (Covidien)
  • Smiths Medical
  • Welch Allyn and Meditech Equipment Co.

To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/pulse-oximeters-market       

Pulse oximeters are instruments that monitor critical health indicators like respiratory rate, heart rate, and pulse rate. These are used to keep track of a patient’s condition before or after a medical diagnosis. Pulse oximeters are used in hospital settings, at home, and in medical emergencies. The market is expected to be driven by factors such as an increase in the geriatric population, a shift toward home monitoring, an increase in the incidence rate of chronic diseases such as cardiovascular disorders and obesity, and increased patient knowledge of advanced pulse oximeters. However, in low- and middle-income countries, a lack of understanding about these devices stifles market development.

The incorporation of artificial intelligence in pulse oximeters is expected to increase demand for these devices in the home and in hospitals in the coming years. With the increased use of mobile-based platforms and wearable devices to determine the degree of oxygen saturation in patients, the demand is increasing. Furthermore, developments in microprocessor technology, as well as advancements in LED and photoelectric sensors, have improved pulse oximeter precision and reliability. To promote the use of pulse oximeters, several businesses are displaying improved versions and waving study results.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/pulse-oximeters-market

COVID-19 Impact Analysis on Pulse Oximeters Market: Pre and Post Pandemic

Since the COVID-19 pandemic has limited visits to medical facilities, medical care systems have been hampered, and manufacturers are developing new devices to offer alternative telehealth solutions. Tyto Care, a telehealth company, released a fingertip pulse oximeter in January 2021 that connects to the TytoCare system through a cable and logs test results to the patient’s EHR, allowing clinicians to track the patient remotely.

In 20219 the pulse oximeter market was dominated by the handheld segment, which accounted for 41.2% of total revenue. The major reason these oximeters are simple to use in case of an emergency is driving the market. The level of oxygen saturation in a patient’s blood may have a direct effect on the treatment’s outcome. Over the projected period, a rising number of stroke cases and surgeries is expected to fuel business growth.

To Know COVID-19 Pre and Post Business Impact Analysis, Request a Free Report PDF Brochure: https://www.fnfresearch.com/sample/pulse-oximeters-market

North America is projected to Dominate Global Pulse Oximeters Market Growth

In 2019, the pulse oximeter market in North America was the biggest. In 2019, the United States had the highest market share in North America, with 80.2 %, and is expected to grow at a CAGR of 7.6 % over the projected period. Because of the increasing pool of elderly patients who are more susceptible to diseases and need pulse oximeters for routine monitoring of their condition, APAC is expected to be the fastest-growing market during the forecast period. Further, due to a large geriatric population, improved healthcare, and the existence of an active American Academy of Pediatrics, which strongly supports the product. The global pulse oximeter market will see substantial growth as a result of all of this.

China is expected to be the fastest-growing market for pulse oximeters in the Asia Pacific region, with a market share of 37.6% by 2026. This is largely due to the widespread use of modern technologies and substantial investment in research and development. The advances have resulted in the creation of lightweight, app-connected as well as patient-friendly pulse oximeters in China, which will fuel the pulse oximeter market’s growth in the coming years.

Request Customized Copy of Report @ https://www.fnfresearch.com/customization/pulse-oximeters-market

(We customize your report according to your research need. Ask our sales team for report customization.)

Due to the rising prevalence of chronic diseases and the increasing geriatric population in India, the pulse oximeters market is expected to grow significantly over the forecast period. Government guidelines requiring pulse oximetry during surgery have led to the company’s strong growth. Pulse oximetry is needed for the detection of both saturation and heart rate, according to the Indian Society of Anaesthesiologists’ recommendations. Furthermore, government spending is increasing. Assisting in disease monitoring R&D would help the Indian market expand faster.

Browse the full “Pulse Oximeters Market By Product Type (Fingertip Oximeter, Handheld Oximeter, Tabletop Oximeter, and Others Oximeter) By End-Use (Hospitals, Healthcare Facilities, Ambulatory Surgical Centers and Homecare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at https://www.fnfresearch.com/pulse-oximeters-market.

The global pulse oximeters market is segmented as follows:

By Product Type:

  • Fingertip
  • Handheld
  • Tabletop
  • Others

By End Use:

  • Hospitals
  • Healthcare Facilities
  • Ambulatory Surgical Centers
  • Homecare

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market

Related Reports:

Biliary Stents Market: https://www.fnfresearch.com/biliary-stents-market

Inhalation Therapy Nebulizer Market: https://www.fnfresearch.com/inhalation-therapy-nebulizer-market-by-product-pneumatic-nebulizers-1292

Medical Gases and Equipment Market: https://www.fnfresearch.com/medical-gases-and-equipment-market-by-type-medical-1277

Smart Inhalers Market: https://www.fnfresearch.com/smart-inhalers-market-by-product-inhalers-and-nebulizers-1273

Nasal Filters Market: https://www.fnfresearch.com/nasal-filters-market-by-type-filter-changeable-type-1269

 About Facts & Factors (FnF Research):

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us Twitter: https://twitter.com/fnfresearch

Contact Us:

Facts & Factors

USA: +1-347-989-3985

Email: [email protected]

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Enghouse Video Partners With SONIFI Health To Deliver Advanced Telehealth Solutions In Hospital Rooms

Published

on

enghouse-video-partners-with-sonifi-health-to-deliver-advanced-telehealth-solutions-in-hospital-rooms

MARKHAM, ON, April 25, 2024 /PRNewswire/ — Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings.

SONIFI Health is a leading U.S. healthcare technology company based in Sioux Falls, South Dakota. The new partnership leverages and integrates Enghouse Video room systems technology to support SONIFI Health’s commitment to expanding telehealth applications and system optimizations in hospital settings.
Enghouse’s VidyoRooms solution, a sophisticated video conferencing technology that combines both software and hardware solutions, has been fully integrated into SONIFI Health’s interactive TV systems. This integration provides up to 4K high-quality video conferencing, multi-party sessions and robust security features that ensure full compliance with healthcare regulations.
Enghouse Video offers an immersive telehealth platform to support collaborative interdisciplinary care, improved patient outcomes and cost savings. The platform is flexible and simple, delivering the reliability, interoperability, and scalability needed for today’s healthcare environment. A key strength of the partnership is its offering of back-end integrations like patient portals, medical devices, EMR, tele-sitting, remote patient observation and consultation.
“Hospitals can choose the telehealth partner that’s right for them, and we incorporate that solution with interactive TV,” said Brian Nido, SONIFI Health’s Vice President of Customer Success. “Using the hardware and systems they already have in patient rooms helps hospitals reduce costs and maximize the value of their existing investments, while benefiting both clinicians and patients.”
SONIFI Health and Enghouse Video continue to collaborate closely to further refine and enhance the telehealth solutions provided to healthcare facilities. This partnership reflects a shared commitment to leveraging technology to create smarter hospital rooms and improve patient care across the healthcare spectrum.
About Enghouse VideoEnghouse Video, part of the Enghouse Interactive division, is a subsidiary of Enghouse Systems Limited, a vertically focused software and services company traded on the Toronto Stock Exchange (TSX: ENGH). Through highly secure, scalable and flexible Cloud-based or On Prem services, we deliver one of the world’s highest quality and most innovative video platform to video-enable any application or idea. From advanced video conferencing and collaboration tools to state-of-art enterprise video management, Enghouse Video is a unique player in multiple markets, including telehealth. Learn more at www.enghousevideo.com, read our blog, or follow us on Twitter at @EnghouseVideo, on LinkedIn, and on Facebook.
About SONIFI HealthSONIFI Health provides market-leading interactive patient engagement technology proven to improve patient outcomes and staff productivity. The EHR-integrated platform is designed to enhance patient and family experiences while increasing staff satisfaction and organizations’ operational efficiencies. As part of SONIFI Solutions, Inc., the company annually supports more than 300 million end user experiences. Learn more at sonifihealth.com.
Enghouse Video Contact: Sylvain Awad, Director, Demand Generation, Enghouse Video, part of Enghouse Interactive Division, [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/enghouse-video-partners-with-sonifi-health-to-deliver-advanced-telehealth-solutions-in-hospital-rooms-302126882.html

Continue Reading

Artificial Intelligence

Global Insurance Provider Selects 3CLogic to Streamline AI and Contact Center Capabilities with ServiceNow

Published

on

global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow

Multinational Insurance Broker to deploy 3CLogic’s solution with ServiceNow’s Financial Service Operations (FSO) platform to streamline customer experiences.
ROCKVILLE, Md., April 25, 2024 /PRNewswire/ — 3CLogic, the leading Conversational AI and Contact Center solution for ServiceNow®, today announced its selection by a global insurance provider to replace its existing contact center infrastructure as part of a larger CX transformation effort. The strategic decision is designed to complement the organization’s use of ServiviceNow’s Financial Services Operations (FSO) offering leveraged across a number of its existing product lines including Customer Warranty Claims, Roadside Assistance, and Home Warranties.

Serving millions of customers worldwide with innovative insurance and protective products, the organization required a solution that would enhance its recent investment in the ServiceNow platform as it works to transform its end-to-end customer service operations. The deployment will incorporate several of 3CLogic’s AI-powered capabilities purpose-built for ServiceNow, including Conversational AI, Speech Analytics, and AI Performance & Coaching, along with integrated call transcriptions, convenient 2-way SMS, and ServiceNow-centralized contact center reporting.
“We continue to see enterprises eager to complement their existing investment in digital platforms, such as ServiceNow, with contact center features purpose-built to extend the workflows and features they already have and use,” explains Matt Durkin, VP of Global Sales at 3CLogic. “It’s no secret that organizations are already juggling too many systems, often with overlapping capabilities, which impacts ROI and operational efficiency. We’re proud to offer an alternative approach that helps simplify the technology stack while optimizing the overall operational costs and outcomes.”
Recently named to Constellation Research’s 2024 Shortlist for Digital Customer Service and Support, 3CLogic has seen global adoption of its solution by leading enterprises in healthcare, manufacturing, travel, retail, higher education, finance, non-profits, and Managed Service Providers across five continents. As a ServiceNow-certified Technology and Build partner with offerings available for ServiceNow’s IT Service Management, Customer Workflows, HR Service Delivery, and Source-to-Pay solutions, the company will be unveiling its latest set of capabilities at ServiceNow’s annual Knowledge 2024 event this May in Las Vegas.
For more information, please contact [email protected].
About 3CLogic3CLogic transforms customer and employee experiences with its leading Cloud Contact Center and AI solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative features such as intelligent self-service, generative and Conversational AI, agent automation & coaching, and AI-powered sentiment analytics – all designed to lower operational costs, maximize ROI, and optimize each interaction across IT Service Desks, Customer Support, Sales or HR Services teams. For more information, please visit www.3clogic.com.
Logo – https://mma.prnewswire.com/media/2318845/3CLogic_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow-302127739.html

Continue Reading

Artificial Intelligence

ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO

Published

on

screenpoint-medical-leadership-transition:-pieter-kroese-confirmed-as-ceo

Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO
NIJMEGEN, Netherlands, April 25, 2024 /PRNewswire/ — ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint’s commercial growth and success over the past 2 years.

 
 
The company’s Board of Directors has appointed Pieter Kroese as the new Chief Executive Officer effective April 25, 2024. Pieter takes the role after serving as COO of ScreenPoint for over five years. During that time, he has managed the transition of the company from an early startup to a thriving enterprise with hundreds of customers using ScreenPoint’s flagship Transpara software to support millions of scans a year.
“I am thrilled to lead ScreenPoint into its next phase of growth and innovation,” said Mr. Kroese. “I am deeply committed to building upon the strong foundation we have and continuing to work closely with our talented team to drive continued success. We are already expanding screening capacity and capability through proven reader support – we look forward to increasing our ability to support providers and women moving forward.”
Sir Michael Brady, Chairman of the Board at ScreenPoint Medical and a co-founder of the company, expressed enthusiasm about Pieter’s appointment, stating, “Pieter’s remarkable leadership qualities, coupled with his depth of knowledge of our product and industry, make him the perfect choice to lead ScreenPoint into the future. His strategic mindset and commitment to excellence align perfectly with our company mission of early breast cancer detection. Pieter has been an integral part of our growth to date and will provide seamless leadership through this transition into our next chapter for our customers, partners, and team.”
Author of “No Longer Radical” and over a hundred peer-reviewed publications on breast imaging, Dr. Rachel Brem is a Transpara user and ScreenPoint Board Member. Dr. Brem welcomed Mr. Kroese with the following: “Pieter has been an integral part of the ScreenPoint team for years. I am confident that his leadership will continue to deliver product excellence: earlier detection with outstanding reading workflow and improved patient outcomes. We continue to see these results from clinical sites all over the world, including many here in the United States. No other Breast AI solution has demonstrated the same results as Transpara, and I am confident that the team will continue to push on these frontiers under Pieter’s leadership.” 
The entire team at ScreenPoint extends its gratitude to Mark Koeniguer and wishes him every success in the future, while warmly welcoming Pieter Kroese into his new role as CEO.
About ScreenPoint Medical
ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment. Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers.
See all the proof at: https://screenpoint-medical.com/evidence.
Photo: https://mma.prnewswire.com/media/2397831/Pieter_Kroese_CEO_ScreenPoint_Medical.jpgLogo: https://mma.prnewswire.com/media/1582198/ScreenPoint_Medical_Logo.jpg
 
 

View original content:https://www.prnewswire.co.uk/news-releases/screenpoint-medical-leadership-transition-pieter-kroese-confirmed-as-ceo-302127719.html

Continue Reading

Trending